6-151536319-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_025059.4(CCDC170):āc.59A>Gā(p.Glu20Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,274 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025059.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC170 | NM_025059.4 | c.59A>G | p.Glu20Gly | missense_variant, splice_region_variant | 2/11 | ENST00000239374.8 | NP_079335.2 | |
CCDC170 | XM_011536147.3 | c.77A>G | p.Glu26Gly | missense_variant, splice_region_variant | 2/11 | XP_011534449.1 | ||
CCDC170 | XM_011536148.3 | c.77A>G | p.Glu26Gly | missense_variant, splice_region_variant | 2/10 | XP_011534450.1 | ||
CCDC170 | XM_047419372.1 | c.59A>G | p.Glu20Gly | missense_variant, splice_region_variant | 2/10 | XP_047275328.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC170 | ENST00000239374.8 | c.59A>G | p.Glu20Gly | missense_variant, splice_region_variant | 2/11 | 1 | NM_025059.4 | ENSP00000239374.6 | ||
CCDC170 | ENST00000544131.1 | n.49A>G | non_coding_transcript_exon_variant | 1/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000481 AC: 12AN: 249264Hom.: 0 AF XY: 0.0000592 AC XY: 8AN XY: 135208
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1460908Hom.: 2 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 726562
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2021 | The c.59A>G (p.E20G) alteration is located in exon 2 (coding exon 2) of the CCDC170 gene. This alteration results from a A to G substitution at nucleotide position 59, causing the glutamic acid (E) at amino acid position 20 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at